Grupo Oncológico Gallego
1 clinical trials · Sponsor
◉ Watch Grupo Oncológico Gallego
| Record | Firm | Date |
|---|---|---|
| Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer (NCT00721747) | Grupo Oncológico Gallego | 2008-01-01 |
Track Grupo Oncológico Gallego automatically
Every clearance here is in the API, with alerts when new ones post.